Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Paul Ausick | Jan 14, 2017 at 10:15 AM EST

Merck Is Best Performing DJIA Stock So Far in 2017

Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.

Chris Lange | Jan 12, 2017 at 3:48 PM EST

Thursday’s Biggest Biopharma Winners

The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the…

Jon C. Ogg | Jan 12, 2017 at 1:20 PM EST

Why 3 Analysts Upgraded Merck Simultaneously

The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed…

Paul Ausick | Jan 12, 2017 at 10:55 AM EST

America’s 400 Richest Taxpayers Could Get $7 Million Tax Cuts If ACA Is Repealed

Obamacare repeal would add $7 million to the annual income of America's 400 richest taxpayers.

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jan 12, 2017 at 9:35 AM EST

Biotech Short Sellers Run for Cover

As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…

Chris Lange | Jan 11, 2017 at 3:22 PM EST

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the…

Chris Lange | Jan 10, 2017 at 3:30 PM EST

Tuesday’s Top Biopharma Movers

Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year,…

Chris Lange | Jan 10, 2017 at 11:05 AM EST

Why Valeant Is Making a Run

Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale…

Lee Jackson | Jan 10, 2017 at 8:35 AM EST

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. The question for investors is which of the…

Chris Lange | Jan 9, 2017 at 11:25 AM EST

Monday’s Merger That No One Saw Coming

Mergers and acquisitions are a way for companies to come together and complement each other’s business models. However, one acquisition…

Chris Lange | Jan 9, 2017 at 9:50 AM EST

Monday’s 4 Biggest Biopharma Movers

As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick…

Douglas A. McIntyre | Jan 7, 2017 at 9:05 AM EST

Can Theranos Make It Through 2017?

Theranos's woes are a nearly perfect storm of loss of faith in its products, loss of faith in management, soured…

Chris Lange | Jan 6, 2017 at 11:55 AM EST

Friday’s 6 Biopharma Movers That Can’t Be Ignored

2017 could be different for the health care sector. It is very possible that this new administration could lead to…

Chris Lange | Jan 6, 2017 at 10:25 AM EST

6 Major FDA Decisions and Biopharma Catalysts Coming in January and February

Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much…

1 … 177 178 179 180 181 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Is Best Performing DJIA Stock So Far in 2017

Thursday’s Biggest Biopharma Winners

Why 3 Analysts Upgraded Merck Simultaneously

America’s 400 Richest Taxpayers Could Get $7 Million Tax Cuts If ACA Is Repealed

Major Pharma Short Interest Declines Ahead of Trump Comments

Biotech Short Sellers Run for Cover

Wednesday’s Top Biopharma Movers

Tuesday’s Top Biopharma Movers

Why Valeant Is Making a Run

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Monday’s Merger That No One Saw Coming

Monday’s 4 Biggest Biopharma Movers

Can Theranos Make It Through 2017?

Friday’s 6 Biopharma Movers That Can’t Be Ignored

6 Major FDA Decisions and Biopharma Catalysts Coming in January and February

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Is Best Performing DJIA Stock So Far in 2017

Thursday’s Biggest Biopharma Winners

Why 3 Analysts Upgraded Merck Simultaneously

America’s 400 Richest Taxpayers Could Get $7 Million Tax Cuts If ACA Is Repealed

Major Pharma Short Interest Declines Ahead of Trump Comments

Biotech Short Sellers Run for Cover

Wednesday’s Top Biopharma Movers

Tuesday’s Top Biopharma Movers

Why Valeant Is Making a Run

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Monday’s Merger That No One Saw Coming

Monday’s 4 Biggest Biopharma Movers

Can Theranos Make It Through 2017?

Friday’s 6 Biopharma Movers That Can’t Be Ignored

6 Major FDA Decisions and Biopharma Catalysts Coming in January and February

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check